This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Discussing the mental health side effects and the use of Singulair (montelukast) for treating pediatric asthma.

Ticker(s): OGN, MRK

Who's the expert?

Institution: Allergy & Asthma Medical Group and Research Center 

  • Fellowship trained in Allergy & Immunology
  • Associate Voluntary Clinical Professor at UCSD in the Division of Allergy/Immunology, and the Co-Director of the Rady Children’s Hospital Allergy Asthma Foundation of America supported Severe Asthma Program as well as  Co- Director of the Multidisciplinary Atopic Dermatitis Program at Rady Childrens Hospital
  • Current President of the San Diego Allergy Society
  • Manages 2 patients with non-advanced systemic mastocytosis and is familiar with the literature to date for Ayvakit

Interview Goal
to discuss the current standard of care and the use of Singulair (montelukast) for treating pediatric asthma.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.